“Glenmark Specialty received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray – a novel fixed-dose combination nasal spray. This paves the way for commercialisation of Ryaltris in Russia which is expected to be made available to patients in the country in Q1 FY 2021-22,” Glenmark Pharmaceuticals said in a regulatory filing.
In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent. Allergic rhinitis can impact a person’s quality of life and lead to functional impairments, as well as increase the risk of having asthma, the company said.
Csaba Kantor Senior Vice President – Russia and CIS region, Glenmark Pharmaceuticals, said Russia is one of the key markets for the company and it consistently looking to expand its product portfolio.
“Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally… This new innovative addition to our portfolio is yet another major step in strengthening Glenmark’s respiratory focus in Russia and the CIS region,” Kantor added.
Shares of Glenmark Pharma were trading 0.18 per cent higher at Rs 483.25 apiece on BSE. SVK ANS ANS
Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their original owners.
Follow Chetas Foundation
Follow this NGO if you are interested in Smart cities,Good Governance,Defending Nation,Cyber Security.If you have anything to do with anyone who works for the government at any level, You should follow this NGO.
Follow this think tank if you work, know or interested in working and knowing about all the international, transnational and global governance,diplomatic relations,world peace and security.
Follow Pune Media on Linkedin
Follow Pune Media
Follow Pune Media for their latest positive coverage,breaking news,polls and much more.
Follow Khumaer Bayas
Follow this account if you want to get the glimpses of things to come, watch interactions with movers and shakers of the world. and in general be updated on issues like #natsec,#opsec,#intsec,#intelissexy the account is followed by few but professional organizations and personnel.